Peptide library / DSIP

DSIP

Delta sleep-inducing peptide is a nine-amino-acid peptide first described in sleep-related experimental research.

Peptide & blend guide

The short version

Why people discuss it
Discussed for sleep onset, sleep continuity and feeling rested. Community interest does not establish benefit or a suitable treatment.
What it is
Delta sleep-inducing peptide is a nine-amino-acid peptide first described in sleep-related experimental research.
Biggest caution
The name does not establish that administered DSIP improves sleep, and the historical literature does not supply a validated modern product or regimen. Human benefit and long-term safety remain uncertain.
Stack context
Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.

Dose and frequency reference

Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.

Sources report different amounts or schedules; the reference below is a named example, not a consensus.

Subcutaneous injection

Community reference · Not clinical guidance
Amount
100–300 mcg
Frequency
Once nightly
Duration / phase
5–10 nights before reassessment

Older short-course community convention. PeptideDosages uses similar nightly amounts but gives 4–8 or 8–12 weeks depending on vial page. The longer schedule is not established by the cited IV research. Reference only; this does not establish safety, effectiveness or individual suitability.

Reference source · reviewed 2026-09-12
Compare reported schedules

Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.

Evidence & sources · Community source profile

AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.

Back to the peptide library